Patho Course Outlines PDF

4.0     Venous Thromboembolism 4.1     Define varicosties. 4.2     List common sites for varicosities. 4.3     Describe the etiology of varicose veins. 4.4     Define: 4.4.1     Phlebitis 4.4.2     Thrombus 4.4.3     Thrombosis 4.4.4     Embolus 4.5     Differentiate between thrombophlebiti...

4.0     Venous Thromboembolism 4.1     Define varicosties. 4.2     List common sites for varicosities. 4.3     Describe the etiology of varicose veins. 4.4     Define: 4.4.1     Phlebitis 4.4.2     Thrombus 4.4.3     Thrombosis 4.4.4     Embolus 4.5     Differentiate between thrombophlebitis and phlebothrombosis. 4.6     Review the etiology of thrombus formation. 4.7     List factors which increase the risk for thrombus formation. 4.8     Identify the contributing factors to the development of Deep Vein Thrombosis post-operatively. 4.9     Identify the potential complications of DVT. 5.0     Pharmacotherapeutics for Venous Thromboembolism 5.1     Complete the Standard Learning Outcomes for anticoagulants. 14.0     Thyroid Disorders 14.1     Briefly review the structure and function of the thyroid and parathyroid glands. 14.2     Describe the formation of a goiter. 14.3     Differentiate the risk-factors, manifestations and care management for hyper and hypothyroidism. 14.4     Discuss the risk factors, pathophysiology, and manifestations of each of the following complications following a thyroidectomy: 14.4.1     Hemorrhage 14.4.2     Respiratory obstruction 14.4.3     Weakness and hoarseness of voice 14.4.4     Thyroid storm 14.4.5     Tetany 15.0     Pharmacotherapeutics for Thyroid Disorders 15.1     Complete the Standard Learning Outcomes for thyroid and antithyroid agents. 32.0     Atherosclerosis 32.1     Define: 32.1.1     Peripheral artery disease 32.1.2     Arteriosclerosis 32.1.3     Atherosclerosis 32.1.4     Lipids 32.1.5     Low density lipoprotein (LDL) 32.1.6     High density lipoprotein (HDL) 32.2     Explain the role of cholesterol and lipoproteins in the development of atheroma. 32.3     List the potential consequences of peripheral artery disease. 32.4     Identify risk factors for atherosclerosis under the headings: 32.4.1     Factors that can be changed 32.4.2     Factors that cannot be changed 32.4.3     Factors associated with aging 33.0     Coronary Artery Disease 33.1     Define Coronary Artery Disease (CAD). 33.2     List predisposing and risk factors for CAD. 33.3     Explain the pathophysiology of angina. 33.4     Differentiate between types of angina. 33.5     Differentiate the three types of acute coronary syndrome (unstable angina, NSTEMI and STEMI). 33.6     Relate pathophysiology associated with the following signs and symptoms of myocardial infarct: 33.6.1     Pain 33.6.2     Diaphoresis 33.6.3     Hypotension 33.7     Explain how these signs and symptoms may differ according to gender. 33.8     Describe the post myocardial infarction serum elevation of specific cardiac enzymes. 33.9     State the response of cells and tissues to the reduced oxygen supplied to the myocardium during and after a myocardial infarct. 33.10     Explain how the location of tissue damage affects patient outcome. 33.11     State the potential complications of a myocardial infarct. 33.12     State the purpose of surgical intervention in myocardial infarct. 34.0     Pharmacotherapeutics for Coronary Artery Disease 34.1     Describe the role of acetylsalicylic acid in the prevention and early management of myocardial infarction. 34.2     Complete the Standard Learning Outcomes for: 34.2.1     Nitrates 34.2.2     Statins 34.2.3     Thrombolytics 34.3     Describe the role of beta blockers in the treatment of coronary artery disease. 35.0     Hypertension 35.1     Define: 35.1.1     Hypertension 35.1.2     Essential hypertension 35.1.3     Secondary hypertension 35.2     Explain the pathophysiology of essential and secondary hypertension. 35.3     Identify possible diagnostic tests used to determine cause and/or effects of hypertension. 35.4     Explain the connection between elevated serum cholesterol levels and hypertension. 35.5     Explain the effect of "white-coat" syndrome on blood pressure. 35.6     Identify possible complications of hypertension. 36.0     Pharmacotherapeutics for Hypertension 36.1     List non-pharmacological interventions recommended for reducing hypertension. 36.2     Explain why diuretics are used to treat hypertension. 36.3     Complete the Standard Learning Outcomes for: 36.3.1     Drugs affecting the Renin-Angiotensin system (ACE inhibitors/ARBs) 36.3.2     Beta blockers 36.3.3     Calcium channel blockers 37.0     Dysrhythmias 37.1     Name and briefly describe common cardiac dysrhythmias and their effect on cardiac output. 37.2     List some potential causes of dysrhythmias. 37.3     Determine benign dysrhythmias from life-threatening dysrhythmias. 37.4     Explain the indications for: 37.4.1     Artificial pacemaker 37.4.2     Defibrillation 37.5     Discuss pharmacological treatment options for atrial fibrillation. 38.0     Heart Failure 38.1     Define heart failure and discuss its etiology. 38.1.1     Differentiate between Heart Failure with Reduced Ejection Fraction (HFrEF) and Hear failure with Preserved Ejection Fraction (HFpEF). 38.2     Discuss why the older adult is at increased risk of heart failure. 38.3     Describe the effects of a failing heart on blood circulation. 38.4     Contrast the pathophysiology and signs and symptoms of left-sided and right-sided heart failure. 38.5     Briefly describe the New York Heart Association (NYHA) classification of heart failure. 38.6     Discuss surgical heart failure treatment options. 39.0     Pharmacotherapeutics for Heart Failure 39.1     Identify the four pillars of heart failure therapy. 39.2     Discuss the role of Furosemide with the management of heart failure.